CAPTURA BIOPHARMA
Captura Biopharma is an biotechnology company engaged in the development and commercialization of heavy metal chelators useful in the treatment of internal radionuclide contamination and heavy metal poisoning. Its lead chelation candidate, C2E2, will be the world's first oral treatment indicated for internal radiation contamination and has been proven in efficacy studies to target select heavy metals, notably americium, plutonium, and lead. Heavy metal contamination, including exposure to transuranic elements, is on the rise.
CAPTURA BIOPHARMA
Social Links:
Industry:
Biopharma Biotechnology Life Science
Founded:
2019-01-01
Address:
Little Rock, Arkansas, United States
Country:
United States
Website Url:
http://www.capturabiopharma.com
Total Employee:
1+
Status:
Active
Contact:
501-516-3905
Email Addresses:
[email protected]
Total Funding:
50 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Global Site Tag Nginx
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Pilot Biotechnology
Pilot Biotechnology is an industrial biotechnology company engaged in the development, production, and sales of health care products.
Current Employees Featured
Founder
Investors List
The Global Emerging Markets Group
The Global Emerging Markets Group investment in Venture Round - Captura Biopharma
Official Site Inspections
http://www.capturabiopharma.com
- Host name: 255.209.73.34.bc.googleusercontent.com
- IP address: 34.73.209.255
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
